A conversation sets VAMS in motion.
Drs. James Rudge and Neil Spooner discuss the limitations of Dried Blood Spot (DBS) cards. This gets James thinking about a dried matrix microsampling tool that will reliably collect fixed-volume samples.
Volumetric absorptive microsampling is born.
Dr. Stuart Kushon and the R&D team at Phenomenex translate James’s idea & prototype for VAMS into a new medical device. Five pharmaceutical companies validate the device, which consistently collects a precise volume of bio-fluid.
Neoteryx LLC is founded in the US.
Neoteryx is formed as a device company with the goal of commercializing tools based on volumetric absorptive microsampling technology. The company offers Mitra® devices with VAMS® in several formats, including the Mitra 96-Autorack for automated, high-throughput processing of multiple samples.
Neoteryx launches VAMS technology.
Mitra® devices based on the original, patented VAMS® technology are registered, trademarked and launched under the Neoteryx banner. Research, healthcare and lab professionals start using Mitra devices with VAMS for a range of applications.
Top organizations adopt Mitra with VAMS.
The NHS, Charles River, Merck and other top science & medicine centers apply Mitra® devices with VAMS® microsampling in pharmaceutical drug discovery & development, clinical research & trials, academic research studies, therapeutic drug monitoring, and public health programs. Hundreds of published studies discuss how VAMS microsampling can be automated for easy workflows and deliver high-quality samples with a 96.8% accuracy rate.
A pandemic spurs wider use of microsampling.
The Coronavirus Pandemic boosts adoption of remote microsampling devices and kits for COVID-19 studies by the National Institutes of Health (NIH) and other research centers that allow people to self-sample at home. Virtual clinical trials and remote patient monitoring improve the patient experience. Thousands of Mitra kits are deployed globally, including new Pediatric Collection Kits tailored for researchers seeking a gentler, safer sampling solution for children.
Neoteryx is acquired by Trajan.
Trajan Scientific and Medical recognizes the promise of microsampling to benefit more people and acquires Neoteryx to expand its microsampling product portfolio. They offer Mitra with VAMS, hemaPEN, and other devices to address a range of needs. Trajan moves closer to realizing its vision of delivering specimen sampling solutions that enable personalized healthcare and preventative medicine for greater global impact.
Neoteryx Launches Program to Support Microsampling Studies
Decentralized Clinical Trials Deliver Benefits, Study Shows
Trajan Licenses Technology to Develop Microbiopsy Device
Neoteryx Releases New Tech Guide on Dried Sample Storage
Trajan Group Holdings Limited Acquires Neoteryx
